Earlier this week, The White House released the Cancer Moonshot report, which calls upon the public and private sectors to transform cancer research and care. Children’s National’s Javad Nazarian, Ph.D., M.S.C., joined peers from prestigious children’s hospitals from around the world at the news conference. Dr. Nazarian is a key player in the initiative, as his lab is part of the Children’s Brain Tumor Tissue Consortium (CBTTC) and is answering the call to action. The CBTTC and the Pacific Pediatric Neuro-Oncology Consortium, in partnership with Seven Bridges, announced the launch of CAVATICA, a data analysis platform that will help researchers to collaboratively access and share data about pediatric cancers, congenital disorders and rare diseases such as epilepsy and autism. More data will be connected than ever before—CAVATICA will interoperate with the Genomic Data Commons and other NIH data repositories. “It’s an exciting time for research,” says Dr. Nazarian.
LATEST TWEETS FROM INNOVATION DISTRICT
Chief Innovation Officer @ChildrensNatl @Eskandanian tells @HealthLeaders 4 ways Children’s National Hospital is striving to #Innovate4Kids ➡️ https://bit.ly/38r9pIp ⬅️
Pediatric innovators! Enter your cardiovascular, orthopedic, spine or NICU devices in the NCC-PDI 2020 pitch competition. Up to $250K in awards. Apply by Feb. 15. More details at ➡️ http://spr.ly/60141d0HC ⬅️ Organized by @childrensNatl @umdbioe @MedTechAwards #innovate4kids